Navidea Biopharmaceuticals (NAVB) Announces the Presentation of Lymphoseek® Data at Joint International Oncology Congress (JIOC)
5/22/2013 7:08:16 AM
More...
|
Nordion International Signs Contract Manufacturing Agreement With Navidea Biopharmaceuticals (NAVB)
5/16/2013 11:42:07 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces First Quarter 2013 Results
5/8/2013 7:55:04 AM
More...
|
Navidea Biopharmaceuticals (NAVB) to Announce First Quarter 2013 Financial Results Pre-Market on Wednesday, May 8, 2013
5/6/2013 7:06:07 AM
More...
|
Navidea Biopharmaceuticals (NAVB) to Announce First Quarter 2013 Financial Results Pre-market on Wednesday, May 8, 2013
5/3/2013 10:02:15 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces the U.S. Launch of Lymphoseek®
5/1/2013 12:01:07 PM
More...
|
Navidea Biopharmaceuticals (NAVB) to Present at the Needham 12th Annual Healthcare Conference
4/26/2013 6:09:18 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces Underwritten Sale of Common Stock
4/24/2013 11:32:42 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces That Results of NAV4694 Clinical Trial Published in the Journal of Nuclear Medicine
4/19/2013 11:27:05 AM
More...
|
Navidea Biopharmaceuticals (NAVB)'s Presentation of Top-Line Interim Analysis of Lymphoseek® Head and Neck Phase 3 Trial Selected for Investigator Award
4/12/2013 9:38:10 AM
More...
|
|